MAP3K13 抗体 (AA 52-305)
Our Local Distributor
北京 101111
Quick Overview for MAP3K13 抗体 (AA 52-305) (ABIN7875559)
抗原
See all MAP3K13 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 52-305
-
原理
- MAP3K13 Antibody
-
纯化方法
- Purified
-
免疫原
- A portion of amino acids 52-305 from the human protein was used as the immunogen for the MAP3K13 antibody.
-
亚型
- IgM
-
-
-
-
应用备注
- The stated application concentrations are suggested starting points. Titration of the MAP3K13 antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Aliquot the MAP3K13 antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- MAP3K13 (Mitogen-Activated Protein Kinase Kinase Kinase 13 (MAP3K13))
-
别名
- MAP3K13
-
背景
- Activates the JUN N-terminal pathway through activation of the MAP kinase kinase MAP2K7. Acts synergistically with PRDX3 to regulate the activation of NF-kappa-B in the cytosol. This activation is kinase-dependent and involves activating the IKK complex, the IKBKB-containing complex that phosphorylates inhibitors of NF-kappa-B.
-
UniProt
- O43283
-
途径
- Signaling Events mediated by VEGFR1 and VEGFR2
抗原
-